AI-generated summary
The authors reviewed 436 patients with ulcerated infantile hemangioma treated at tertiary centers in a retrospective cohort study. They report that median healing time was shortest with wound care alone and longer with timolol, systemic beta-blocker, or multimodal therapy, and that larger hemangioma size was associated with longer healing. Lower propranolol doses were associated with shorter healing time after adjusting for size.
- Participants
- 436
- Who or what was studied
- Consecutive patients with a clinical diagnosis of ulcerated infantile hemangioma treated at tertiary referral centers between 2012 and 2016, with available clinical photographs; 75.0% were girls and median age at ulceration was 13.7 weeks.
- Limits stated in the abstract
- The study is retrospective and observational, so treatment groups were not randomized and associations cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jamanetwork.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.